Switching patients with congenital adrenal hyperplasia to modified‐release hydrocortisone capsules: relative bioavailability and disease control

Ross, R.J.M. orcid.org/0000-0001-9222-9678, Arlt, W. orcid.org/0000-0001-5106-9719, de la Perriere, A.B. et al. (13 more authors) (2025) Switching patients with congenital adrenal hyperplasia to modified‐release hydrocortisone capsules: relative bioavailability and disease control. Clinical Endocrinology. ISSN 0300-0664

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/

Keywords: 21-hydroxylase deficiency; adrenal insufficiency; congenital adrenal hyperplasia; glucocorticoid; hydrocortisone; MRHC
Dates:
  • Submitted: 24 February 2025
  • Accepted: 16 May 2025
  • Published (online): 16 May 2025
  • Published: 8 May 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 19 May 2025 14:19
Last Modified: 19 May 2025 14:19
Status: Published online
Publisher: Wiley
Refereed: Yes
Identification Number: 10.1111/cen.15275
Open Archives Initiative ID (OAI ID):

Export

Statistics